Walleye Trading
INO icon

Walleye Trading’s Inovio Pharmaceuticals INO Stock Holding History

Walleye Trading’s Portfolio INO Stock Details INO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-7,042
Closed -$303K – 5383
2022
Q1 		$303K Buy
7,042
+2,942
+72% +$133K ﹤0.01% 3435
2021
Q4 		$246K Buy
4,100
+1,967
+92% +$158K ﹤0.01% 3680
2021
Q3 		$183K Buy
2,133
+100
+5% +$10K ﹤0.01% 3940
2021
Q2 		$226K Buy
+2,033
New +$195K ﹤0.01% 3797
2020
Q4 		– Sell
-175
Closed -$24K – 4746
2020
Q3 		$24K Buy
+175
New +$36.5K ﹤0.01% 3807

Other funds holding INO

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Walleye Trading's INO Position: Q4 2022 in Review

Walleye Trading sold out of Inovio Pharmaceuticals (INO) in Q4 2022, closing a stake of 949 shares — an estimated $20K sold.

Walleye Trading first reported a position in INO in Q2 2015 and held it in 5 quarters. The position peaked at $77K in Q4 2015. 183 funds tracked by Wall St. Rank hold INO as of Q4 2022.

  • Walleye Trading reported no remaining Inovio Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Walleye Trading sold 949 Inovio Pharmaceuticals shares in Q4 2022, an estimated $20K.
  • Walleye Trading first reported a position in Inovio Pharmaceuticals in Q2 2015 and held it in 5 quarters.
  • Walleye Trading's Inovio Pharmaceuticals position peaked at $77K in Q4 2015.
  • 183 funds tracked by Wall St. Rank held Inovio Pharmaceuticals as of Q4 2022.

Based on Walleye Trading's 13F filing for Q4 2022, filed 14 Feb 2023.